Merck (MRK)
$92.15
0.10 (0.11%)
MRK Stock Quote Delayed 30 Minutes
10 Stocks to Sell in May and Go Away
If you're going to "sell in may and go away," this group of 10 stocks deserves close consideration thanks to lousy fundamentals and weak stock charts.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$90.58
Market Cap
229.13B
PE Ratio
13.68
EPS
6.7363
Volume (Avg. Vol.)
14.13M
Day's Range
$90.71 - $92.35
52-Week Range
$81.04 - $132.70
Dividend & Yield
$3.12 (3.39%)
MRK Stock Predictions, Articles, and Merck News
Prepare for Earnings Season with These 49 Trades
It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 49 trades to consider
2 Drug Stocks To Buy For Safe Dividends And 20% Gains
With all the talk on the campaign trail about drug costs, it's safe to say the pharmaceutical industry is under siege. But these drug stocks are solid buys
64 Actions to Take on Monday’s Market Dip
It pays to stay on top of the latest profit opportunities, and today's blog post is a great place to start after Monday's route
4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY
Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside?
60 Recommendations for the Earnings Shakeout
these times it pays to stay on top of the latest profit opportunities. Today's post is be the place to start with these 70 stock moves
63 Trades to Kick Off the Week
During these busy times, it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start.
The Long Trail Back For the Energy Sector
Kinder Morgan's recent move to cut its dividend signals a start to a long road back for the energy sector
Should You Buy Merck Stock? 3 Pros, 3 Cons (MRK)
Merck (MRK) hasn't had a great 2015, but 2016 should serve up more of a tailwind than a headwind for owners of Merck stock.
How the Stench of Deflation Fouls the Market Air
Deciding how the economy will react to an expected rate hike is difficult. Here's how we can invest while waiting for the Fed's details
Merck: The Smart Way to Buy Into Healthcare (MRK)
Merck is the very definition of big pharma – and solid growth, especially through good use of M&A.
Apple Inc. Earnings Solid as Stocks Await Fed
Big Pharma lifted healthcare, but Apple's earnings beat after the bell was too late to save the Nasdaq.
Microsoft is Among This List of Upgrades For the Week
It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 71 stock picks
